Global Blood Cell Analyzer Market to Reach $2.4 Billion by 2030
The global market for Blood Cell Analyzer estimated at US$1.7 Billion in the year 2022, is projected to reach a revised size of US$2.4 Billion by 2030, growing at a CAGR of 4.9% over the analysis period 2022-2030. Semi-automated Biochemistry Analyzers, one of the segments analyzed in the report, is projected to record 4.5% CAGR and reach US$629.1 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Fully Automated Biochemistry Analyzers segment is readjusted to a revised 5% CAGR for the next 8-year period.The U.S. Market is Estimated at $499.6 Million, While China is Forecast to Grow at 4.5% CAGR
The Blood Cell Analyzer market in the U.S. is estimated at US$499.6 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$425.6 Million by the year 2030 trailing a CAGR of 4.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.7% and 3.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4% CAGR.Select Competitors (Total 43 Featured) -
- Abbott Laboratories
- Bio-Rad Laboratories, Inc.
- Boule Diagnostics AB
- Cellavision AB
- Danaher Corporation
- F. Hoffmann-La Roche AG
- Horiba Ltd.
- Siemens Healthineers
- Sysmex Corporation
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and the publisher's Research Platform
- Complimentary updates for one year
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Bio-Rad Laboratories, Inc.
- Boule Diagnostics AB
- Cellavision AB
- Danaher Corporation
- F. Hoffmann-La Roche AG
- Horiba Ltd.
- Siemens Healthineers
- Sysmex Corporation
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 193 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 1.7 Billion |
Forecasted Market Value ( USD | $ 2.4 Billion |
Compound Annual Growth Rate | 4.4% |
Regions Covered | Global |